Philip D Davies, Director, Vice President, Global Sales & Marketing, on May 01, 2026, sold 3,073 shares in Vicor (VICR) for $826,851. Following the Form 4 filing with the SEC, Davies has control over a total of 1,920 common shares of the company, with 1,920 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/751978/000151286826000004/xslF345X05/primary_doc.xml
Price: $250.17, Change: $-18.34, Percent Change: -6.83%
Shawn Marie Soderberg, Chief Legal Officer and Corporate Secretary, on April 29, 2026, sold 35,000 shares in Bloom Energy (BE) for $9,765,000. Following the Form 4 filing with the SEC, Soderberg has control over a total of 482,463 Class A common shares of the company, with 140,732 shares held directly and 341,731 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1664703/000119312526201723/xslF345X05/ownership.xml
Helen T Meates, Chief Financial Officer, on May 01, 2026, sold 8,000 shares in PJT Partners (PJT) for $1,225,560. Following the Form 4 filing with the SEC, Meates has control over a total of 58,466 Class A common shares of the company, with 58,466 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1626115/000119312526201703/xslF345X05/ownership.xml
James Edgemond, CFO and Treasurer, on April 30, 2026, sold 10,000 shares in United Therapeutics (UTHR) for $5,726,062. Following the Form 4 filing with the SEC, Edgemond has control over a total of 18,876 common shares of the company, with 18,876 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1082554/000163617826000014/xslF345X05/primarydocument.xml